ICU (SeaStar Medical Holding) OCF Yield %: -107.84 (As of Jun. 27, 2026)


ICU SeaStar Medical Holding Corp ICU
31 GF Score
Price $3.18
! 4 Warning Signs
View Full Analysis

What is SeaStar Medical Holding OCF Yield %?

SeaStar Medical Holding ICU +4.70% 31 OCF Yield % is -107.84 as of Jun. 27, 2026. GuruFocus rates ICU with a GF Score™ of 31/100. The stock has 4 warning signs investors should review. Among 1,419 Biotechnology companies, SeaStar Medical Holding ranks worse than 91.61% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, SeaStar Medical Holding's Trailing 12-Month Cash Flow from Operations is $-13.71 Mil, and Market Cap is $12.71 Mil. Therefore, SeaStar Medical Holding's OCF Yield % for today is -107.84%.

The historical rank and industry rank for SeaStar Medical Holding's OCF Yield % or its related term are showing as below:

ICU' s OCF Yield % Range Over the Past 10 Years
Min: -499.35   Med: -147.37   Max: -77.91
Current: -107.84

During the past 6 years, the highest OCF Yield % of SeaStar Medical Holding was -77.91%. The lowest was -499.35%. And the median was -147.37%.

ICU's OCF Yield % is ranked worse than
91.61% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs ICU: -107.84

SeaStar Medical Holding's OCF Margin % for the quarter that ended in Mar. 2026 was %.

SeaStar Medical Holding OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

SeaStar Medical Holding OCF Yield % Related Terms

SeaStar Medical Holding OCF Yield % Historical Data

* Premium members only.

The historical data trend for SeaStar Medical Holding's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SeaStar Medical Holding OCF Yield % Chart

SeaStar Medical Holding Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial 0.00 -14.91 -48.91 -137.98 -147.37

SeaStar Medical Holding Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -69.06 -162.94 -79.11 -177.46 -74.33

ICU vs MBRX, LEXX, INTI: OCF Yield % Comparison

For the Biotechnology subindustry, SeaStar Medical Holding's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SeaStar Medical Holding OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeaStar Medical Holding's OCF Yield % distribution charts can be found below:

* The bar in red indicates where SeaStar Medical Holding's OCF Yield % falls into.


ICU
31GF Score
SeaStar Medical Holding Corp ICU
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SeaStar Medical Holding OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

SeaStar Medical Holding's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-13.599 / 9.228
=-147.37%

SeaStar Medical Holding's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-2.761 * 4 / 14.85768
=-74.33%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -107.84 mean?
SeaStar Medical Holding (ICU) has a OCF Yield % of -107.84 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SeaStar Medical Holding and its competitors. According to the industry distribution chart, SeaStar Medical Holding ranks #1300 out of 1419 companies in the Biotechnology industry, placing it in the top 91.6%.
Is SeaStar Medical Holding's OCF Yield % too high?
SeaStar Medical Holding's current OCF Yield % is -107.84. Based on the distribution chart, SeaStar Medical Holding ranks #1300 out of 1419 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, SeaStar Medical Holding has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does SeaStar Medical Holding's OCF Yield % compare to MBRX and LEXX?
According to the Biotechnology industry distribution chart, SeaStar Medical Holding ranks #1300 out of 1419 companies for OCF Yield %. This places SeaStar Medical Holding in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SeaStar Medical Holding and its competitors. SeaStar Medical Holding's current OCF Yield % is -107.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SeaStar Medical Holding stock overvalued right now?
SeaStar Medical Holding (ICU) has a current OCF Yield % of -107.84. The current OCF Yield % is -107.84. SeaStar Medical Holding's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For SeaStar Medical Holding (ICU), the current OCF Yield % is -107.84 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SeaStar Medical Holding Business Description

Address 3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
31GF Score

Get the complete analysis for ICU

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.18
Price